NasdaqGM - Delayed Quote USD

Keros Therapeutics, Inc. (KROS)

Compare
59.33 -0.97 (-1.61%)
At close: October 22 at 4:00 PM EDT
59.33 0.00 (0.00%)
After hours: October 22 at 4:18 PM EDT
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-143,802.00
-124,508.00
-70,062.00
-62,148.00
-36,894.00
--
Investing Cash Flow
-2,347.00
-2,464.00
-1,241.00
-1,024.00
-294.00
--
Financing Cash Flow
229,871.00
178,956.00
120,309.00
28,550.00
296,044.00
--
End Cash Position
407,075.00
332,359.00
280,375.00
231,369.00
265,991.00
--
Income Tax Paid Supplemental Data
--
--
--
--
--
256.00
Capital Expenditure
-2,347.00
-2,464.00
-1,241.00
-1,024.00
-294.00
--
Issuance of Capital Stock
220,486.00
175,825.00
119,578.00
28,171.00
299,202.00
--
Free Cash Flow
-146,149.00
-126,972.00
-71,303.00
-63,172.00
-37,188.00
--
12/31/2019 - 4/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers